Decreased polydipsia in schizophrenic patients treated with naloxone. 1994

T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida

UI MeSH Term Description Entries
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012565 Schizophrenic Psychology Study of mental processes and behavior of schizophrenics. Psychology, Schizophrenic

Related Publications

T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
March 1989, Journal of behavior therapy and experimental psychiatry,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
June 1997, The Journal of clinical psychiatry,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
March 1991, The American journal of psychiatry,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
August 1996, Journal of clinical psychopharmacology,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
October 1997, Biological psychiatry,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
August 1977, Psychopharmacology,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
January 1999, The Journal of neuropsychiatry and clinical neurosciences,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
January 1984, Atherosclerosis,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
February 1999, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
T Nishikawa, and A Tsuda, and M Tanaka, and M Nishikawa, and I Koga, and Y Uchida
September 1996, Schizophrenia research,
Copied contents to your clipboard!